Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA crosslinking via platinum agents refers to the process by which platinum-based chemotherapy drugs, such as oxaliplatin, form covalent bonds between DNA strands or between DNA and proteins. This disrupts essential cellular processes like replication and transcription, ultimately leading to cell death. Oxaliplatin primarily forms intrastrand crosslinks at guanine and adenine bases.
Covalent binding to DNA, forming intra- and interstrand crosslinks, disrupting replication and transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Crosslinking via Platinum Agent (Oxaliplatin).